Publications by authors named "Rodney Decker"

Claim this Profile
A
A Population Pharmacokinetic and Exposure-Response Analysis for Baricitinib in Pediatric Patients with Atopic Dermatitis.
Rodney L Decker, C Steven Ernest, David B Radtke, Apurva Prakash, Xin Zhang

Clin Pharmacokinet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritis.
Rodney L Decker, C Steven Ernest, David B Radtke, Rona Wang, Joana Araújo

CPT Pharmacometrics Syst Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsampling in pediatric studies: pharmacokinetic sampling for baricitinib (Olumiant™) in global pediatric studies.
Enaksha R Wickremsinhe, Rodney L Decker, Lisa B Lee, Erica Lelle, Lena A Carlton

Bioanalysis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.
Eddy S Yang, Eric Deutsch, Altan Mehmet, Jerome Fayette, Yungan Tao, Rodney L Decker

Radiother Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of LY2599666, a PEG-Linked Antigen Binding Fragment that Targets Soluble Monomer Amyloid-β.
Li Li, Eugene Y Zhen, Rodney L Decker, Brian A Willis, David Waters

J Alzheimers Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.
Victor M Villalobos, Gary Mo, Mark Agulnik, Seth M Pollack, Daniel A Rushing, Rodney L Decker

Cancer Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.
Lindsay B Kilburn, Mehmet Kocak, Rodney L Decker, Cynthia Wetmore, Murali Chintagumpala

Neuro Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patients.
Scott M Hynes, Enaksha Wickremsinhe, Wei Zhang, Rodney Decker, Jennifer Ott

Biopharm Drug Dispos· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics.
Nwabundo Nwankwo, Zhe Zhang, Ting Wang, Connie Collins, Lee Resta, Rodney Decker

Invest New Drugs· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation and pharmacokinetics study of enzastaurin and sunitinib versus placebo and sunitinib in patients with metastatic renal cell carcinoma.
Manuela Schmidinger, Cezary Szczylik, Cora N Sternberg, Marek Kania, Claudia Sue Kelly, Rodney Decker

Am J Clin Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors.
Sukhmani K Padda, Yelena Krupitskaya, Laveena Chhatwani, George A Fisher, Alexander D Colevas, Rodney Decker

Cancer Chemother Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).
Roy Rampling, Marc Sanson, Thiery Gorlia, Denis Lacombe, Christina Lai, Rodney Decker

Neuro Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis